Abstract
In the Russian Federation, the WHO program was launched in 1994 and it covered the whole country by 2005. Detection and therapeutic efficiency are suboptimal. The proportion of pulmonary tuberculosis averages 34.5% (21.0-61.0%). In terms of cessation of bacterial isolation, therapeutic efficiency averages 61.4% with a scatter of 37.4-75.0%. Social support has a considerable impact on the efficiency of treatment.
MeSH terms
-
Academic Medical Centers*
-
Antibiotics, Antitubercular / therapeutic use*
-
Cohort Studies
-
Humans
-
Incidence
-
Mass Screening / methods*
-
Mycobacterium tuberculosis / isolation & purification
-
Pilot Projects
-
Prevalence
-
Russia / epidemiology
-
Treatment Outcome
-
Tuberculosis, Pulmonary / drug therapy*
-
Tuberculosis, Pulmonary / epidemiology*
-
Tuberculosis, Pulmonary / microbiology
Substances
-
Antibiotics, Antitubercular